Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2070]
News [6432]
Articles [133]
Editorials [5]
Conferences [170]
elearning [10]
Integrated genomic correlates of response to PD-1 inhibitor nivolumab in mRCC
Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA
Integrated genomic correlates of response to PD-1 inhibitor nivolumab in mRCC ( Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016
Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following...
Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA
Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following cystectomy for bladder cancer ( Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016
Molecular genetics of testicular cancer: What does the clinician need to know?
Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA
Molecular genetics of testicular cancer: What does the clinician need to know? ( Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016
Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer
Prof Eleni Efstathiou and Prof Nick James
Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer ( Prof Eleni Efstathiou and Prof Nick James )
7 Jan 2016
Actionable targets in patients with cisplatin-resistant advanced germ cell...
Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA
Actionable targets in patients with cisplatin-resistant advanced germ cell tumours ( Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA )
7 Jan 2016
Global cancer partnership
Dr Lisa Stevens - National Cancer Institute, Washington, USA
Global cancer partnership ( Dr Lisa Stevens - National Cancer Institute, Washington, USA )
17 Dec 2015
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response...
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response in triple-negative breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )
17 Dec 2015
ER and FGFR1 interaction critical in endocrine resistant breast cancer
Dr Luigi Formisano - Vanderbilt University Nashville, USA
ER and FGFR1 interaction critical in endocrine resistant breast cancer ( Dr Luigi Formisano - Vanderbilt University Nashville, USA )
16 Dec 2015
Interrupting breast cancer treatment for young women who desire pregnancy
Dr Olivia Pagani and Dr Ann Partridge
Interrupting breast cancer treatment for young women who desire pregnancy ( Dr Olivia Pagani and Dr Ann Partridge )
16 Dec 2015
New developments and technologies in hereditary cancer
Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake...
New developments and technologies in hereditary cancer ( Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake City, USA )
14 Dec 2015
Hormonal treatments produce similar quality of life outcomes in DCIS
Prof Patricia Ganz - UCLA, Los Angeles, USA
Hormonal treatments produce similar quality of life outcomes in DCIS ( Prof Patricia Ganz - UCLA, Los Angeles, USA )
11 Dec 2015
Treating women with endocrine-resistant HR /HER2 advanced breast cancer
Dr Mario Campone - René Gauducheau Centre de Recherche en Cancérologie...
Treating women with endocrine-resistant HR /HER2 advanced breast cancer ( Dr Mario Campone - René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. )
11 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation